tiprankstipranks
Trending News
More News >
Advertisement

JP:2624 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
13Bullish
5Neutral
4Bearish
Oscillators
Neutral
3Bullish
5Neutral
2Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
2Bearish
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Moving Averages Convergence Divergence (MACD) indicator is 65.34, suggesting iFreeETF-Nikkei225(Quarterly Dividend Type) is a Sell.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 20-Day exponential moving average is 4026.99, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 50-Day exponential moving average is 3922.74, making it a Buy.

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Pivot Points

Jul 31, 2025, 08:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4,125.33
4,142.67
4,156.33
4,173.67
4,187.33
4,204.67
4,218.33
Fibonacci
4,142.67
4,154.51
4,161.82
4,173.67
4,185.51
4,192.82
4,204.67

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Moving Averages

Jul 31, 2025, 08:49 AM
Period
Simple
Exponential
MA5
4,125.40Sell
4,120.51Sell
MA10
4,054.70Buy
4,079.40Buy
MA20
4,024.60Buy
4,026.99Buy
MA50
3,902.73Buy
3,922.74Buy
MA100
3,757.00Buy
3,846.51Buy
MA200
3,815.49Buy
3,823.25Buy
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 10-Day exponential moving average is 4079.40, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 100-Day exponential moving average is 3846.51, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 50-day simple moving average is 3902.73, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 100-day simple moving average is 3757.00, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 200-day simple moving average is 3815.49, creating a Buy signal.

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Technical Analysis

Jul 31, 2025, 08:49 AM
Name
Value
Action
RSI (14)
63.91
Neutral
STOCH (9,6)
78.74
Neutral
STOCHRSI (14)
79.02
Neutral
MACD (12,26)
65.34
Sell
ADX (14)
26.49
Neutral
Williams %R
-38.13
Buy
CCI (14)
126.20
Sell
ATR (14)
53.94
-
Ultimate Oscillator
55.48
Neutral
ROC
3.70
Buy
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Relative Strength Index (RSI) is 63.91, creating a Neutral signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Trend Strength Indicator (ADX) is 26.49, creating a Neutral signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Commodity Channel Index (CCI) is 126.20, creating a Sell signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Price Rate of Change (ROC) is 3.70, creating a Buy signal.

FAQ

Is 2624 a Buy, Hold, or Sell?
Based on 2624’s technical indicators, 2624 is a Buy.
    What is 2624’s RSI (14)?
    2624’s RSI (14) is 63.91, which suggests 2624 is a Neutral.
      What is 2624’s MACD?
      2624’s MACD is 65.34, which suggests 2624 is a Sell.
        What is 2624’s 5-day moving average?
        2624’s 5-day moving average is 4125.40, which suggests 2624 is a Sell.
          What is 2624’s 20-day moving average?
          2624 20-day moving average is 4024.60, which suggests 2624 is a Buy.
            What is 2624’s 50-day moving average?
            2624’s 50-day moving average is 3902.73, which suggests 2624 is a Buy.
              What is 2624’s 200-day moving average?
              2624’s 200-day moving average is 3815.49, which suggests 2624 is a Buy.
                What is 2624’s Williams % R (14)?
                2624’s Williams % R (14) is -38.13, which suggests 2624 is a Buy.
                  What is 2624’s CCI (14)?
                  2624’s CCI (14) is 126.20, which suggests 2624 is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement